Skip to main content
Caplight Logo









AllRock Bio

AllRock Bio

Private
Natick, MassachusettsHealthcare & Life Scienceshttps://allrockbio.com/

Last Round

Series A

Sep 16, 2025

Est. Valuation

$67M

Total Funding Raised

$50M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AllRock Bio is a biotechnology company developing therapies for cardiopulmonary and fibrotic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, E-commerce

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverybiotechbiochemical reagentsresearch chemicalssmall molecule therapeuticsclinical stage biotechlife science researchclinical developmentmolecular biologylab suppliespharma R&Dbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AllRock Bio Comparables

Compare AllRock Bio with similar companies based on industry and business-model similarity.

AllRock Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Redx Pharma Plc
36%
tiakis Biotech AG
34%
MBQ Pharma
34%

AllRock Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 16, 2025

Key People

Founding team and executive leadership

Catherine J. Pearce

CEO and Founder

Founding Team

Andrea Ledford

Chief Financial Officer

Executive Team

AllRock Bio Investors

Notable investors and investment history

AllRock Bio investors
InvestorRounds
Westlake Village BioPartnersSeries A
Versant VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 30, 2026

    Monthly visitors increased 36% MoM.

  • Nov 15, 2025

    Grew 240% QoQ from 5 to 17 employees.

AllRock Bio Filings

Explore SEC and related filing metadata, where available.

AllRock Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AllRock Bio's valuation, stock price, and market status.

Is AllRock Bio a public or private company?

AllRock Bio is a private company.

What is the current stock price of AllRock Bio?

AllRock Bio is a private company with no public stock price. No recent secondary market data is available.

How much is AllRock Bio worth (valuation)?

Valuation information for AllRock Bio is not publicly available.

Can I buy AllRock Bio stock?

AllRock Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AllRock Bio's last funding round?

AllRock Bio's most recent funding round was Series A on September 16, 2025.

Who are the main investors in AllRock Bio?

Key investors in AllRock Bio include Westlake Village Biopartners, Versant Ventures.

Will AllRock Bio IPO soon?

No public IPO plans have been announced for AllRock Bio.

How can I track AllRock Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AllRock Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNatick, Massachusetts
Employee Range17
Year Founded2024
Last FundingSep 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?